Position in KURA
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$12,826,001
+$1,233,070 QoQ
Shares Held
1,169,189
-18.0% QoQ
Ownership
1.31%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#18
of 220 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 88%
Shared 6%
None 6%
Common Shares in KURA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DIMENSIONAL FUND ADVISORS LP holds $6,163,799,259 across 230 Biotechnology names. KURA ranks #71 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,168,956 | $580,655,511 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
1,713,592 | $412,924,262 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
559,687 | $348,987,230 | |
| 4 | INCY |
Incyte Corp
|
2,280,803 | $258,551,825 | |
| 5 | EXEL |
Exelixis, Inc.
|
4,426,620 | $240,852,392 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
4,075,714 | $233,212,353 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
5,230,417 | $185,104,455 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
476,038 | $176,929,041 |
All Filings in KURA
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,826,001 | 1,169,189 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $11,592,931 | 1,425,945 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $11,198,527 | 1,077,818 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $10,083,379 | 1,139,365 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $7,171,716 | 1,242,932 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $8,991,997 | 1,362,424 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $12,420,109 | 1,425,960 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $20,590,546 | 1,053,764 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $18,420,203 | 894,619 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $29,082,067 | 1,363,435 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $28,785,219 | 2,001,754 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $16,454,520 | 1,804,224 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $20,225,318 | 1,911,656 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $22,443,074 | 1,835,084 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $21,111,542 | 1,701,172 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $21,482,493 | 1,572,657 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $25,288,340 | 1,379,615 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $17,216,614 | 1,070,685 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $10,843,140 | 774,510 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $12,179,013 | 650,241 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $15,852,400 | 760,307 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $23,155,730 | 819,092 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $21,180,336 | 648,510 | Shares | Defined | 2021-03-08 | |
| 2020-09-30 | $19,072,296 | 622,464 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $9,651,148 | 592,095 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $5,501,444 | 552,909 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||